Research Focus
My project looks at the metabolic mechanisms of drug resistance in acute myeloid leukaemia (AML). By using a combination of techniques, from –omics scale techniques to metabolic profiling of live cells, we look to understand what makes certain cells more vulnerable to AML treatment and how we can use this to improve overall treatment strategies.